ASPIRE BIOPHARMA HOLDINGS, INC.
ASBP ASBPWCIK 0001847345
Revenue (TTM)
$6.2K
Q1 May 2026
Net Income (TTM)
−$23M
−1,768.9% YoY
Q1 May 2026
EPS Diluted (TTM)
−$525.50
−762.1% YoY
Q1 May 2026
Gross Margin
-1.9%
Q1 May 2026
Operating Margin
-299,313.2%
Q1 May 2026
Net Margin
-370,783.7%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$5.86M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
1.3M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.